Skip to main content

Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry.

Publication ,  Journal Article
McKay, RR; Gold, T; Zarif, JC; Chowdhury-Paulino, IM; Friedant, A; Gerke, T; Grant, M; Hawthorne, K; Heath, E; Huang, FW; Jackson, MD ...
Published in: JCO Glob Oncol
April 2021

Prostate cancer disproportionately affects racial and ethnic minority populations. Reasons for disparate outcomes among minority patients are multifaceted and complex, involving factors at the patient, provider, and system levels. Although advancements in our understanding of disease biology have led to novel therapeutics for men with advanced prostate cancer, including the introduction of biomarker-driven therapeutics, pivotal translational studies and clinical trials are underrepresented by minority populations. Despite attempts to bridge the disparities gap, there remains an unmet need to expand minority engagement and participation in clinical trials to better define the impact of therapy on efficacy outcomes, quality of life, and role of biomarkers in diverse patient populations. The IRONMAN registry (ClinicalTrials.gov identifier: NCT03151629), a global, prospective, population-based study, was borne from this unmet medical need to address persistent gaps in our knowledge of advanced prostate cancer. Through integrated collection of clinical outcomes, patient-reported outcomes, epidemiologic data, and biospecimens, IRONMAN has the goal of expanding our understanding of how and why prostate cancer outcomes differ by race and ethnicity. To this end, the Diversity Working Group of the IRONMAN registry has developed informed strategies for site selection, recruitment, engagement and retention, and trial design and eligibility criteria to ensure broad inclusion and needs awareness of minority participants. In concert with systematic strategies to tackle the complex levels of disparate care, our ultimate goal is to expand minority engagement in clinical research and bridge the disparities gap in prostate cancer care.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JCO Glob Oncol

DOI

EISSN

2687-8941

Publication Date

April 2021

Volume

7

Start / End Page

495 / 505

Location

United States

Related Subject Headings

  • Registries
  • Quality of Life
  • Prostatic Neoplasms
  • Prospective Studies
  • Minority Groups
  • Male
  • Humans
  • Ethnicity
  • Clinical Trials as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McKay, R. R., Gold, T., Zarif, J. C., Chowdhury-Paulino, I. M., Friedant, A., Gerke, T., … Mucci, L. A. (2021). Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry. JCO Glob Oncol, 7, 495–505. https://doi.org/10.1200/GO.20.00571
McKay, Rana R., Theresa Gold, Jelani C. Zarif, Ilkania M. Chowdhury-Paulino, Adam Friedant, Travis Gerke, Marie Grant, et al. “Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry.JCO Glob Oncol 7 (April 2021): 495–505. https://doi.org/10.1200/GO.20.00571.
McKay RR, Gold T, Zarif JC, Chowdhury-Paulino IM, Friedant A, Gerke T, et al. Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry. JCO Glob Oncol. 2021 Apr;7:495–505.
McKay, Rana R., et al. “Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry.JCO Glob Oncol, vol. 7, Apr. 2021, pp. 495–505. Pubmed, doi:10.1200/GO.20.00571.
McKay RR, Gold T, Zarif JC, Chowdhury-Paulino IM, Friedant A, Gerke T, Grant M, Hawthorne K, Heath E, Huang FW, Jackson MD, Mahal B, Ogbeide O, Paich K, Ragin C, Rencsok EM, Simmons S, Yates C, Vinson J, Kantoff PW, George DJ, Mucci LA. Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry. JCO Glob Oncol. 2021 Apr;7:495–505.

Published In

JCO Glob Oncol

DOI

EISSN

2687-8941

Publication Date

April 2021

Volume

7

Start / End Page

495 / 505

Location

United States

Related Subject Headings

  • Registries
  • Quality of Life
  • Prostatic Neoplasms
  • Prospective Studies
  • Minority Groups
  • Male
  • Humans
  • Ethnicity
  • Clinical Trials as Topic